Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
10.1172/JCI59755 69 MengX.AnX.ZhouL.FuB.JiaL
Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement
Funding The authors declare that no funds or grants were received for this specific manuscript
:46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India
Explainable deep learning in plant phenotyping
BAT is currently a primary target organ in obesity prevention strategies [137]
US$ 28.50
US$ 22.65
US$ 29.15
US$ 25.11
US$ 20.08
US$ 22.17
US$ 29.26
